Skip to main content
Premium Trial:

Request an Annual Quote

Collins Talks Cuts, NCATS

Both Science Insider and Nature's News blog report on National Institutes of Health Director Francis Collins' talk at a Senate hearing on Capitol Hill this week, in which he warned that the grant-funding success rate could drop below 20 percent for the 2011 fiscal year. According to Nature, Collins "projected, 'with some uncertainty,' that success rates for scientists trying to win grants from his agency will end up between 17 percent and 18 percent." He also told the Senate Appropriations Subcommittee on Labor, Health and Human Services and Education that that success rate would "be the lowest in history," adding that "for every six grants, we will fund one of them, and five are going to go begging." Science adds that during the hearing, Collins also defended the proposed National Center for Advancing Translational Sciences — the creation of which would "shift at least $1.3 billion" among various institutes, Senator Richard Shelby (R-AL) said, calling for a "thoughtful consideration to the effect that [NCATS] will have on the NIH, the extramural research community, and the private pharmaceutical world." Collins responded that the proposed NIH reorganization is "a complicated process," but that he sees the proposed center as essential "to move the science forward." Collins told the Senate subcommittee that he'd have submitted a budget plan for the proposed center "in the next few weeks," Science adds.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.